MM

Maximus IncNYSE MMS Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

5.312

Middle

Exchange

XNYS - New York Stock Exchange, Inc

MMS Stock Analysis

MM

Neutral

Based on Eyestock quantitative analysis, MMS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

61/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

10.2 %

Undervalued

Market cap $B

5.312

Dividend yield

1.36 %

Shares outstanding

60.773 B

MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. The company is headquartered in Mclean, Virginia and currently employs 39,500 full-time employees. The firm operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment provides a variety of business process services (BPS), such as program administration, appeals and assessments, and related consulting work for United States state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions that help various United States federal government agencies, including program operations and management, clinical services, and technology solutions. The Outside the U.S. segment provides BPS for international governments and commercial clients. The services provided by the segment include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services.

View Section: Eyestock Rating